146 related articles for article (PubMed ID: 30266448)
1. Automated closed-system manufacturing of human monocyte-derived dendritic cells for cancer immunotherapy.
Erdmann M; Uslu U; Wiesinger M; Brüning M; Altmann T; Strasser E; Schuler G; Schuler-Thurner B
J Immunol Methods; 2018 Dec; 463():89-96. PubMed ID: 30266448
[TBL] [Abstract][Full Text] [Related]
2. Automated Good Manufacturing Practice-compliant generation of human monocyte-derived dendritic cells from a complete apheresis product using a hollow-fiber bioreactor system overcomes a major hurdle in the manufacture of dendritic cells for cancer vaccines.
Uslu U; Erdmann M; Wiesinger M; Schuler G; Schuler-Thurner B
Cytotherapy; 2019 Nov; 21(11):1166-1178. PubMed ID: 31668486
[TBL] [Abstract][Full Text] [Related]
3. Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.
Wong EC; Lee SM; Hines K; Lee J; Carter CS; Kopp W; Bender J; Read EJ
Cytotherapy; 2002; 4(1):65-76. PubMed ID: 11953043
[TBL] [Abstract][Full Text] [Related]
4. Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectors.
Gulen D; Abe F; Maas S; Reed E; Cowan K; Pirruccello S; Wisecarver J; Warkentin P; Northam M; Turken O; Coskun U; Senesac J; Talmadge JE
Int Immunopharmacol; 2008 Dec; 8(13-14):1728-36. PubMed ID: 18793758
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a fully GMP-compliant production process of autologous, tumor-lysate-pulsed dendritic cells.
Eyrich M; Schreiber SC; Rachor J; Krauss J; Pauwels F; Hain J; Wölfl M; Lutz MB; de Vleeschouwer S; Schlegel PG; Van Gool SW
Cytotherapy; 2014 Jul; 16(7):946-64. PubMed ID: 24831836
[TBL] [Abstract][Full Text] [Related]
6. Effective clinical-scale production of dendritic cell vaccines by monocyte elutriation directly in medium, subsequent culture in bags and final antigen loading using peptides or RNA transfection.
Erdmann M; Dörrie J; Schaft N; Strasser E; Hendelmeier M; Kämpgen E; Schuler G; Schuler-Thurner B
J Immunother; 2007 Sep; 30(6):663-74. PubMed ID: 17667530
[TBL] [Abstract][Full Text] [Related]
7. Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS prodigy.
Mock U; Nickolay L; Philip B; Cheung GW; Zhan H; Johnston ICD; Kaiser AD; Peggs K; Pule M; Thrasher AJ; Qasim W
Cytotherapy; 2016 Aug; 18(8):1002-1011. PubMed ID: 27378344
[TBL] [Abstract][Full Text] [Related]
8. Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
Pullarkat V; Lau R; Lee SM; Bender JG; Weber JS
J Immunol Methods; 2002 Sep; 267(2):173-83. PubMed ID: 12165439
[TBL] [Abstract][Full Text] [Related]
9. Immune activation of the monocyte-derived dendritic cells using patients own circulating tumor cells.
Kolostova K; Pospisilova E; Matkowski R; Szelachowska J; Bobek V
Cancer Immunol Immunother; 2022 Dec; 71(12):2901-2911. PubMed ID: 35471603
[TBL] [Abstract][Full Text] [Related]
10. Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study.
Babatz J; Röllig C; Oelschlägel U; Zhao S; Ehninger G; Schmitz M; Bornhäuser M
J Hematother Stem Cell Res; 2003 Oct; 12(5):515-23. PubMed ID: 14594508
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dendritic cell generation for clinical use: recovery and purity of monocytes and mature dendritic cells after immunomagnetic sorting or adherence selection of CD14+ starting populations.
Meyer-Wentrup F; Burdach S
J Hematother Stem Cell Res; 2003 Jun; 12(3):289-99. PubMed ID: 12857370
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Human NK Cell Manufacturing: Fully Automated Separation, Improved Ex Vivo Expansion Using IL-21 with Autologous Feeder Cells, and Generation of Anti-CD123-CAR-Expressing Effector Cells.
Klöß S; Oberschmidt O; Morgan M; Dahlke J; Arseniev L; Huppert V; Granzin M; Gardlowski T; Matthies N; Soltenborn S; Schambach A; Koehl U
Hum Gene Ther; 2017 Oct; 28(10):897-913. PubMed ID: 28810809
[TBL] [Abstract][Full Text] [Related]
13. Generation of dendritic cells for immunotherapy is minimally impaired by granulocytes in the monocyte preparation.
ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; Vrielink H; Marieke van Ham S
Immunobiology; 2006; 211(6-8):633-40. PubMed ID: 16920502
[TBL] [Abstract][Full Text] [Related]
14. Efficient elutriation of monocytes within a closed system (Elutra) for clinical-scale generation of dendritic cells.
Berger TG; Strasser E; Smith R; Carste C; Schuler-Thurner B; Kaempgen E; Schuler G
J Immunol Methods; 2005 Mar; 298(1-2):61-72. PubMed ID: 15847797
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines.
Dohnal AM; Graffi S; Witt V; Eichstill C; Wagner D; Ul-Haq S; Wimmer D; Felzmann T
J Cell Mol Med; 2009 Jan; 13(1):125-35. PubMed ID: 18363835
[TBL] [Abstract][Full Text] [Related]
16. Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.
Shinde P; Fernandes S; Melinkeri S; Kale V; Limaye L
Sci Rep; 2018 Apr; 8(1):5705. PubMed ID: 29632307
[TBL] [Abstract][Full Text] [Related]
17. GMP-Compliant Manufacturing of NKG2D CAR Memory T Cells Using CliniMACS Prodigy.
Fernández L; Fernández A; Mirones I; Escudero A; Cardoso L; Vela M; Lanzarot D; de Paz R; Leivas A; Gallardo M; Marcos A; Romero AB; Martínez-López J; Pérez-Martínez A
Front Immunol; 2019; 10():2361. PubMed ID: 31649672
[TBL] [Abstract][Full Text] [Related]
18. A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.
Jarnjak-Jankovic S; Hammerstad H; Saebøe-Larssen S; Kvalheim G; Gaudernack G
BMC Cancer; 2007 Jul; 7():119. PubMed ID: 17608923
[TBL] [Abstract][Full Text] [Related]
19. Automated Clinical Grade Expansion of Regulatory T Cells in a Fully Closed System.
Marín Morales JM; Münch N; Peter K; Freund D; Oelschlägel U; Hölig K; Böhm T; Flach AC; Keßler J; Bonifacio E; Bornhäuser M; Fuchs A
Front Immunol; 2019; 10():38. PubMed ID: 30778344
[TBL] [Abstract][Full Text] [Related]
20. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.
Ueda Y; Itoh T; Fuji N; Harada S; Fujiki H; Shimizu K; Shiozaki A; Iwamoto A; Shimizu T; Mazda O; Kimura T; Sonoda Y; Taniwaki M; Yamagishi H
Cancer Immunol Immunother; 2007 Mar; 56(3):381-9. PubMed ID: 16830156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
